139 related articles for article (PubMed ID: 35081519)
1. Dictionary-based software for proton dose reconstruction and submilimetric range verification.
Onecha VV; Galve P; Ibáñez P; Freijo C; Arias-Valcayo F; Sanchez-Parcerisa D; España S; Fraile LM; Udías JM
Phys Med Biol; 2022 Feb; 67(4):. PubMed ID: 35081519
[No Abstract] [Full Text] [Related]
2. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
3. Two-stage ionoacoustic range verification leveraging Monte Carlo and acoustic simulations to stably account for tissue inhomogeneity and accelerator-specific time structure - A simulation study.
Patch SK; Hoff DEM; Webb TB; Sobotka LG; Zhao T
Med Phys; 2018 Feb; 45(2):783-793. PubMed ID: 29159885
[TBL] [Abstract][Full Text] [Related]
4. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans.
Knopf A; Parodi K; Bortfeld T; Shih HA; Paganetti H
Phys Med Biol; 2009 Jul; 54(14):4477-95. PubMed ID: 19556685
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
7. Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy.
Frey K; Unholtz D; Bauer J; Debus J; Min CH; Bortfeld T; Paganetti H; Parodi K
Phys Med Biol; 2014 Oct; 59(19):5903-19. PubMed ID: 25211629
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking a GATE/Geant4 Monte Carlo model for proton beams in magnetic fields.
Padilla-Cabal F; Alejandro Fragoso J; Franz Resch A; Georg D; Fuchs H
Med Phys; 2020 Jan; 47(1):223-233. PubMed ID: 31661559
[TBL] [Abstract][Full Text] [Related]
9. Simulation studies of time reversal-based protoacoustic reconstruction for range and dose verification in proton therapy.
Yu Y; Li Z; Zhang D; Xing L; Peng H
Med Phys; 2019 Aug; 46(8):3649-3662. PubMed ID: 31199511
[TBL] [Abstract][Full Text] [Related]
10. Automatic detection and classification of treatment deviations in proton therapy from realistically simulated prompt gamma imaging data.
Pietsch J; Khamfongkhruea C; Berthold J; Janssens G; Stützer K; Löck S; Richter C
Med Phys; 2023 Jan; 50(1):506-517. PubMed ID: 36102783
[TBL] [Abstract][Full Text] [Related]
11. Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning.
Tian L; Huang Z; Janssens G; Landry G; Dedes G; Kamp F; Belka C; Pinto M; Parodi K
Phys Med Biol; 2021 Feb; 66(5):055005. PubMed ID: 33171445
[TBL] [Abstract][Full Text] [Related]
12. PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.
Parodi K; Paganetti H; Cascio E; Flanz JB; Bonab AA; Alpert NM; Lohmann K; Bortfeld T
Med Phys; 2007 Feb; 34(2):419-35. PubMed ID: 17388158
[TBL] [Abstract][Full Text] [Related]
13. Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.
Testa M; Schümann J; Lu HM; Shin J; Faddegon B; Perl J; Paganetti H
Med Phys; 2013 Dec; 40(12):121719. PubMed ID: 24320505
[TBL] [Abstract][Full Text] [Related]
14. Dictionary-based protoacoustic dose map imaging for proton range verification.
Freijo C; Herraiz JL; Sanchez-Parcerisa D; Udias JM
Photoacoustics; 2021 Mar; 21():100240. PubMed ID: 33520652
[TBL] [Abstract][Full Text] [Related]
15. Development and verification of an analytical algorithm to predict absorbed dose distributions in ocular proton therapy using Monte Carlo simulations.
Koch NC; Newhauser WD
Phys Med Biol; 2010 Feb; 55(3):833-53. PubMed ID: 20071765
[TBL] [Abstract][Full Text] [Related]
16. Range shift verification in spot scanning proton therapy using gamma electron vertex imaging.
Kim SH; Jeong JH; Ku Y; Lee SB; Shin D; Lim YK; Kim H; Kim CH
Med Phys; 2024 Mar; 51(3):1985-1996. PubMed ID: 37722712
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.
Almeida IP; Schyns LEJR; Vaniqui A; van der Heyden B; Dedes G; Resch AF; Kamp F; Zindler JD; Parodi K; Landry G; Verhaegen F
Phys Med Biol; 2018 May; 63(11):115008. PubMed ID: 29616662
[TBL] [Abstract][Full Text] [Related]
18. Independent dose verification system with Monte Carlo simulations using TOPAS for passive scattering proton therapy at the National Cancer Center in Korea.
Shin WG; Testa M; Kim HS; Jeong JH; Lee SB; Kim YJ; Min CH
Phys Med Biol; 2017 Sep; 62(19):7598-7616. PubMed ID: 28809759
[TBL] [Abstract][Full Text] [Related]
19. Acoustic-based proton range verification in heterogeneous tissue: simulation studies.
Jones KC; Nie W; Chu JCH; Turian JV; Kassaee A; Sehgal CM; Avery S
Phys Med Biol; 2018 Jan; 63(2):025018. PubMed ID: 29176057
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the physical potential of proton beam range verification with PET/CT.
Knopf A; Parodi K; Paganetti H; Cascio E; Bonab A; Bortfeld T
Phys Med Biol; 2008 Aug; 53(15):4137-51. PubMed ID: 18635897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
